IDEAYA Biosciences Inc. (30J)
XDUS
Closed
Oct 23, 2026
Day's Range
30.9652 wk Range
23.60Overview - 30J - IDEAYA Biosciences Inc.
Key Statistics
Valuation
Enterprise Value
-84.91M
P/E (Trailing)
-25.15
PEG Ratio
-0.65
Price / Book
2.47
EV / EBITDA
0.54
Profitability
Operating Margin
-72.84%
Return on Assets
-10.24%
Return on Equity
-11.11%
Ownership
Shares Outstanding
96.37M
Price stats
50-Day Avg
32.92
200-Day Avg
29.17
Peers - 30J - IDEAYA Biosciences Inc.
Peer Comparison
Compared with companies in Biotechnology listed on XDUS.
- 30JXDUSIDEAYA Biosciences Inc.+28.57%52-week change-25.16P/E (Trailing)—Profit Margin
- 0QFXDUSModerna Inc.+88.57%52-week change—P/E (Trailing)—Profit Margin
- 2LBXDUSIovance Biotherapeutics Inc.+84.52%52-week change-11.14P/E (Trailing)34.27%Profit Margin
- 3920XDUSSpyre Therapeutics, Inc.+76.32%52-week change-38.38P/E (Trailing)—Profit Margin
- 0MEXDUSTwist Bioscience Corporation+75.54%52-week change-91.00P/E (Trailing)50.72%Profit Margin
- 42ZXDUSRevolution Medicines, Inc.+75.52%52-week change-28.70P/E (Trailing)—Profit Margin
- 7BGXDUSOncoinvent ASA+72.12%52-week change-0.05P/E (Trailing)—Profit Margin
Profile Summary - 30J - IDEAYA Biosciences Inc.
About
IDEAYA Biosciences Inc. is a precision medicine oncology company focused on discovering and developing targeted therapies for cancers defined by specific genetic alterations and biomarker profiles. The company combines small-molecule drug discovery, structural biology, bioinformatics, and translational biomarker…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
